New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 1, 2014
07:11 EDTVRXValeant shares offer greater upside potential than downside, says FBR Captial
FBR Capital sees greater upside potential than downside risk in shares of Valeant (VRX) following yesterday's sell-off. The firm says it sees limited downside in the stock and significant upside potential if the Allergan (AGN) merger is consummated. FBR keeps an Outperform rating on Valeant with a $148 price target.
News For VRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 22, 2015
05:57 EDTVRXActavis, Valeant raise prospects of more healthcare deals, Financial Times says
Subscribe for More Information
January 21, 2015
12:30 EDTVRXGlaxoSmithKline 'admired' by Pfizer CEO, FT reports
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use